Patents by Inventor Francesco Sergio

Francesco Sergio has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • N-acetylcysteine for use as antibacterial agent
    Patent number: 11918552
    Abstract: The present invention relates to N-acetylcysteine for the use in the treatment of bacterial infections caused by a pathogen selected from Burkholderia cepacia complex (BCC) and Stenotrophomonas maltophilia (S. maltophilia) strains.
    Type: Grant
    Filed: December 28, 2020
    Date of Patent: March 5, 2024
    Assignee: Zambon S.P.A.
    Inventors: Gian Maria Rossolini, Lucia Pallecchi, Francesco Sergio
  • ASSOCIATION OF N-ACETYLCYSTEINE AND COLISTIN FOR USE IN BACTERIAL INFECTIONS
    Publication number: 20220370549
    Abstract: A synergistic pharmacological association of N-acetylcysteine (NAC) and colistin for use in the treatment of a bacterial infection caused by one or more pathogens selected from S. maltophilia and A. baumannii strains, in particular a bacterial infection associated with a respiratory tract disease, such as a chronic respiratory tract disease comprising cystic fibrosis (CF), bronchiectasis non CF and chronic obstructive pulmonary disease COPD is described.
    Type: Application
    Filed: May 20, 2022
    Publication date: November 24, 2022
    Applicant: Zambon S.P.A.
    Inventors: Lucia Pallecchi, Francesco Sergio, Gian Maria Rossolini
  • Association of N-acetylcysteine and colistin for use in bacterial infections
    Patent number: 11382948
    Abstract: A synergistic pharmacological association of N-acetylcysteine (NAC) and colistin for use in the treatment of a bacterial infection caused by one or more pathogens selected from S. maltophilia and A. baumannii strains, in particular a bacterial infection associated with a respiratory tract disease, such as a chronic respiratory tract disease comprising cystic fibrosis (CF), bronchiectasis non CF and chronic obstructive pulmonary disease (COPD) is described.
    Type: Grant
    Filed: February 26, 2018
    Date of Patent: July 12, 2022
    Assignee: Zaambon S.P.A.
    Inventors: Lucia Pallecchi, Francesco Sergio, Gian Maria Rossolini
  • ASSOCIATION OF N-ACETYLCYSTEINE AND COLISTIN FOR USE IN BACTERIAL INFECTIONS
    Publication number: 20210128678
    Abstract: The present invention relates to a synergistic pharmacological association of NAC and colistin for use in the treatment of a bacterial infection caused by one or more pathogens selected from S. maltophilia and A. baumannii strains, in particular a bacterial infection associated with a respiratory tract disease, such as a chronic respiratory tract disease comprising CF, bronchiectasis non CF and COPD.
    Type: Application
    Filed: February 26, 2018
    Publication date: May 6, 2021
    Applicant: Zambon S.P.A.
    Inventors: Lucia Pallecchi, Francesco Sergio, Gian Maria Rossolini
  • N-ACETYLCYSTEINE FOR USE AS ANTIBACTERIAL AGENT
    Publication number: 20210113508
    Abstract: The present invention relates to N-acetylcysteine for the use in the treatment of bacterial infections caused by a pathogen selected from Burkholderia cepacia complex (BCC) and Stenotrophomonas maltophilia (S. maltophilia) strains.
    Type: Application
    Filed: December 28, 2020
    Publication date: April 22, 2021
    Applicant: Zambon S.P.A.
    Inventors: Gian Maria Rossolini, Lucia Pallecchi, Francesco Sergio
  • N-ACETYLCYSTEINE FOR USE AS ANTIBACTERIAL AGENT
    Publication number: 20200093774
    Abstract: The present invention relates to N-acetylcysteine for the use in the treatment of bacterial infections caused by a pathogen selected from Burkholderia cepacia complex (BCC) and Stenotrophomonas maltophilia (S. maltophilia) strains.
    Type: Application
    Filed: December 13, 2017
    Publication date: March 26, 2020
    Applicant: Zambon S.P.A.
    Inventors: Gian Maria Rossolini, Lucia Pallecchi, Francesco Sergio